Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
c-FOS suppresses ovarian cancer progression by changing adhesion.
Oliveira-Ferrer L, Rößler K, Haustein V, Schröder C, Wicklein D, Maltseva D, Khaustova N, Samatov T, Tonevitsky A, Mahner S, Jänicke F, Schumacher U, Milde-Langosch K. Oliveira-Ferrer L, et al. Br J Cancer. 2014 Feb 4;110(3):753-63. doi: 10.1038/bjc.2013.774. Epub 2013 Dec 5. Br J Cancer. 2014. PMID: 24322891 Free PMC article.
Prognostic relevance of glycosylation-associated genes in breast cancer.
Milde-Langosch K, Karn T, Schmidt M, zu Eulenburg C, Oliveira-Ferrer L, Wirtz RM, Schumacher U, Witzel I, Schütze D, Müller V. Milde-Langosch K, et al. Breast Cancer Res Treat. 2014 Jun;145(2):295-305. doi: 10.1007/s10549-014-2949-z. Epub 2014 Apr 16. Breast Cancer Res Treat. 2014. PMID: 24737166
Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties.
Oliveira-Ferrer L, Kürschner M, Labitzky V, Wicklein D, Müller V, Lüers G, Schumacher U, Milde-Langosch K, Schröder C. Oliveira-Ferrer L, et al. J Cancer Res Clin Oncol. 2015 Oct;141(10):1715-26. doi: 10.1007/s00432-015-1925-2. Epub 2015 Feb 10. J Cancer Res Clin Oncol. 2015. PMID: 25666264
Selectin-independent adhesion during ovarian cancer metastasis.
Khaustova NA, Maltseva DV, Oliveira-Ferrer L, Stürken C, Milde-Langosch K, Makarova JA, Rodin S, Schumacher U, Tonevitsky AG. Khaustova NA, et al. Biochimie. 2017 Nov;142:197-206. doi: 10.1016/j.biochi.2017.09.009. Epub 2017 Sep 14. Biochimie. 2017. PMID: 28919578
Loss of BRCA1 promotor hypermethylation in recurrent high-grade ovarian cancer.
Prieske K, Prieske S, Joosse SA, Trillsch F, Grimm D, Burandt E, Mahner S, Schmalfeldt B, Milde-Langosch K, Oliveira-Ferrer L, Woelber L. Prieske K, et al. Oncotarget. 2017 Sep 15;8(47):83063-83074. doi: 10.18632/oncotarget.20945. eCollection 2017 Oct 10. Oncotarget. 2017. PMID: 29137324 Free PMC article.
74 results